<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38672710</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Effects of Hyperbaric Oxygen Therapy on Long COVID: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">438</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14040438</ELocationID><Abstract><AbstractText>The coronavirus disease (COVID-19) pandemic has resulted in an increasing population that is experiencing a wide range of long-lasting symptoms after recovery from the acute infection. Long COVID refers to this specific condition and is associated with diverse symptoms, such as fatigue, myalgias, dyspnea, headache, cognitive impairment, neurodegenerative symptoms, anxiety, depression, and a sense of despair. The potential of hyperbaric oxygen therapy (HBOT) to improve chronic fatigue, cognitive impairments, and neurological disorders has been established; therefore, the use of HBOT to treat long COVID has also been studied. We conducted a literature search between 1 January 2019 and 30 October 2023, focusing on the clinical efficacy and utility of HBOT for treating long COVID and found ten clinical studies that fit the review topic, including one case report, five one-group pretest-posttest design studies, one safety report from a randomized controlled trial (RCT), and three complete reports of RCTs. Most studies found that HBOT can improve quality of life, fatigue, cognition, neuropsychiatric symptoms, and cardiopulmonary function. Although HBOT has shown some benefits for long COVID symptoms, further rigorous large-scale RCTs are required to establish precise indications, protocols, and post-treatment evaluations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Bing-Qi</ForeName><Initials>BQ</Initials><Identifier Source="ORCID">0009-0004-9123-5389</Identifier><AffiliationInfo><Affiliation>Department of Education, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>De-Yi</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0009-0008-9920-712X</Identifier><AffiliationInfo><Affiliation>Department of Education, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung 404, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Te-Chun</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0002-9427-1068</Identifier><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hyperbaric Oxygen Therapy Center, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Chu Shang Show Chwan Hospital, Nantou 557, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Yu-Ru</ForeName><Initials>YR</Initials><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung 404, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Tsai-Ling</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung 404, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Hsiang-Li</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Education, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung 404, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hsiu-Ming</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Education, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung 404, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Wei-Chih</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hyperbaric Oxygen Therapy Center, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsia</LastName><ForeName>Te-Chun</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>School of Medicine, China Medical University, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hyperbaric Oxygen Therapy Center, China Medical University Hospital, Taichung 404, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronavirus disease (COVID-19)</Keyword><Keyword MajorTopicYN="N">hyperbaric oxygen (HBO)</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID conditions</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38672710</ArticleId><ArticleId IdType="pmc">PMC11051078</ArticleId><ArticleId IdType="doi">10.3390/life14040438</ArticleId><ArticleId IdType="pii">life14040438</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., Houben-Wilke S., Burtin C., Posthuma R., Franssen F.M.E., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: The post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghajani Mir M. Brain fog: A narrative review of the most common mysterious cognitive disorder in COVID-19. Mol. Neurobiol. 2023 doi: 10.1007/s12035-023-03715-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-023-03715-y</ArticleId><ArticleId IdType="pubmed">37874482</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziolos N.R., Ioannou P., Baliou S., Kofteridis D.P. Long COVID-19 pathophysiology: What do we know so far? Microorganisms. 2023;11:2458. doi: 10.3390/microorganisms11102458.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11102458</ArticleId><ArticleId IdType="pmc">PMC10609046</ArticleId><ArticleId IdType="pubmed">37894116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega M.A., Fraile-Martinez O., Garc&#xed;a-Montero C., Callej&#xf3;n-Pel&#xe1;ez E., S&#xe1;ez M.A., &#xc1;lvarez-Mon M.A., Garc&#xed;a-Honduvilla N., Monserrat J., &#xc1;lvarez-Mon M., Bujan J., et al. A general overview on the hyperbaric oxygen therapy: Applications, mechanisms and translational opportunities. Medicina. 2021;57:864. doi: 10.3390/medicina57090864.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57090864</ArticleId><ArticleId IdType="pmc">PMC8465921</ArticleId><ArticleId IdType="pubmed">34577787</ArticleId></ArticleIdList></Reference><Reference><Citation>Somaa F. A Review of the application of hyperbaric oxygen therapy in Alzheimer&#x2019;s disease. J. Alzheimers Dis. 2021;81:1361&#x2013;1367. doi: 10.3233/JAD-210157.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-210157</ArticleId><ArticleId IdType="pubmed">33935095</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., You J., Ma H., Zhou M., Huang C. Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: A systematic review and meta-analysis. BMJ Open. 2023;13:e062322. doi: 10.1136/bmjopen-2022-062322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-062322</ArticleId><ArticleId IdType="pmc">PMC9872467</ArticleId><ArticleId IdType="pubmed">36690401</ArticleId></ArticleIdList></Reference><Reference><Citation>Balasubramanian P., Delfavero J., Nyul-Toth A., Tarantini A., Gulej R., Tarantini S. Integrative role of hyperbaric oxygen therapy on healthspan, age-related vascular cognitive impairment, and dementia. Front. Aging. 2021;2:678543. doi: 10.3389/fragi.2021.678543.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fragi.2021.678543</ArticleId><ArticleId IdType="pmc">PMC9261405</ArticleId><ArticleId IdType="pubmed">35821996</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottfried I., Schottlender N., Ashery U. Hyperbaric oxygen treatment-from mechanisms to cognitive improvement. Biomolecules. 2021;11:1520. doi: 10.3390/biom11101520.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11101520</ArticleId><ArticleId IdType="pmc">PMC8533945</ArticleId><ArticleId IdType="pubmed">34680155</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcinkowska A.B., Mankowska N.D., Kot J., Winklewski P.J. Impact of hyperbaric oxygen therapy on cognitive functions: A systematic review. Neuropsychol. Rev. 2022;32:99&#x2013;126. doi: 10.1007/s11065-021-09500-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-021-09500-9</ArticleId><ArticleId IdType="pmc">PMC8888529</ArticleId><ArticleId IdType="pubmed">33847854</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Villalobos I., Casanova-Maldonado I., Lois P., Prieto C., Pizarro C., Lattus J., Osorio G., Palma V. Hyperbaric oxygen increases stem cell proliferation, angiogenesis and wound-healing ability of WJ-MSCs in diabetic mice. Front. Physiol. 2018;9:995. doi: 10.3389/fphys.2018.00995.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00995</ArticleId><ArticleId IdType="pmc">PMC6078002</ArticleId><ArticleId IdType="pubmed">30104981</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregorevic P., Lynch G.S., Williams D.A. Hyperbaric oxygen modulates antioxidant enzyme activity in rat skeletal muscles. Eur. J. Appl. Physiol. 2001;86:24&#x2013;27. doi: 10.1007/s004210100503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004210100503</ArticleId><ArticleId IdType="pubmed">11820317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Daugherty W.P., Sun D., Levasseur J.E., Altememi N., Hamm R.J., Rockswold G.L., Bullock M.R. Protection of mitochondrial function and improvement in cognitive recovery in rats treated with hyperbaric oxygen following lateral fluid-percussion injury. J. Neurosurg. 2007;106:687&#x2013;694. doi: 10.3171/jns.2007.106.4.687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/jns.2007.106.4.687</ArticleId><ArticleId IdType="pubmed">17432723</ArticleId></ArticleIdList></Reference><Reference><Citation>Efrati S., Fishlev G., Bechor Y., Volkov O., Bergan J., Kliakhandler K., Kamiager I., Gal N., Friedman M., Ben-Jacob E., et al. Hyperbaric oxygen induces late neuroplasticity in post stroke patients&#x2014;Randomized, prospective trial. PLoS ONE. 2013;8:e53716. doi: 10.1371/journal.pone.0053716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0053716</ArticleId><ArticleId IdType="pmc">PMC3546039</ArticleId><ArticleId IdType="pubmed">23335971</ArticleId></ArticleIdList></Reference><Reference><Citation>Tal S., Hadanny A., Berkovitz N., Sasson E., Ben-Jacob E., Efrati S. Hyperbaric oxygen may induce angiogenesis in patients suffering from prolonged post-concussion syndrome due to traumatic brain injury. Restor. Neurol. Neurosci. 2015;33:943&#x2013;951. doi: 10.3233/RNN-150585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/RNN-150585</ArticleId><ArticleId IdType="pubmed">26484702</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie M., Enomoto M., Shimoda M., Okawa A., Miyakawa S., Yagishita K. Enhancement of satellite cell differentiation and functional recovery in injured skeletal muscle by hyperbaric oxygen treatment. J. Appl. Physiol. 2014;116:149&#x2013;155. doi: 10.1152/japplphysiol.00235.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00235.2013</ArticleId><ArticleId IdType="pubmed">24336879</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita N., Ono M., Tomioka T., Deie M. Effects of hyperbaric oxygen at 1.25 atmospheres absolute with normal air on macrophage number and infiltration during rat skeletal muscle regeneration. PLoS ONE. 2014;9:e115685. doi: 10.1371/journal.pone.0115685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115685</ArticleId><ArticleId IdType="pmc">PMC4274106</ArticleId><ArticleId IdType="pubmed">25531909</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaiyat A.M., Sasson E., Wang Z., Khairy S., Ginzarly M., Qureshi U., Fikree M., Efrati S. Hyperbaric oxygen treatment for long coronavirus disease-19: A case report. J. Med. Case Rep. 2022;16:80. doi: 10.1186/s13256-022-03287-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-022-03287-w</ArticleId><ArticleId IdType="pmc">PMC8848789</ArticleId><ArticleId IdType="pubmed">35168680</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins T., Gonevski M., Clark C., Baitule S., Sharma K., Magar A., Patel K., Sankar S., Kyrou I., Ali A., et al. Hyperbaric oxygen therapy for the treatment of long COVID: Early evaluation of a highly promising intervention. Clin. Med. 2021;21:e629&#x2013;e632. doi: 10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Zant A.E., Figueroa X.A., Paulson C.P., Wright J.K. Hyperbaric oxygen therapy to treat lingering COVID-19 symptoms. Undersea Hyperb. Med. 2022;49:333&#x2013;339. doi: 10.22462/05.06.2022.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.22462/05.06.2022.7</ArticleId><ArticleId IdType="pubmed">36001566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitala D., &#x141;abu&#x15b; W., Kozielski J., Strzelec P., Nowak M., Knefel G., Dyjas P., Materniak K., Kosmala J., Paj&#x105;k J., et al. Preliminary research on the effect of hyperbaric oxygen therapy in patients with post-COVID-19 syndrome. J. Clin. Med. 2022;12:308. doi: 10.3390/jcm12010308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12010308</ArticleId><ArticleId IdType="pmc">PMC9821575</ArticleId><ArticleId IdType="pubmed">36615108</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic-Sposta S., Vezzoli A., Garetto G., Paganini M., Camporesi E., Giacon T.A., Dellanoce C., Agrimi J., Bosco G. Hyperbaric oxygen therapy counters oxidative stress/inflammation-driven symptoms in long COVID-19 patients: Preliminary outcomes. Metabolites. 2023;13:1032. doi: 10.3390/metabo13101032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13101032</ArticleId><ArticleId IdType="pmc">PMC10608857</ArticleId><ArticleId IdType="pubmed">37887357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenmann J., Porubsky C., Okresa L., Klemen H., Mykoliuk I., Roj A., Koutp A., Kink E., Iberer F., Kovacs G., et al. Immediate and long-term effects of hyperbaric oxygenation in patients with long COVID-19 syndrome using SF-36 survey and VAS score: A clinical pilot study. J. Clin. Med. 2023;12:6253. doi: 10.3390/jcm12196253.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12196253</ArticleId><ArticleId IdType="pmc">PMC10573231</ArticleId><ArticleId IdType="pubmed">37834897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjellberg A., Hassler A., Bostr&#xf6;m E., El Gharbi S., Al-Ezerjawi S., Kowalski J., Rodriguez-Wallberg K.A., Bruchfeld J., St&#xe5;hlberg M., Nygren-Bonnier M., et al. Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial. BMC Infect. Dis. 2023;23:33. doi: 10.1186/s12879-023-08002-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08002-8</ArticleId><ArticleId IdType="pmc">PMC9854077</ArticleId><ArticleId IdType="pubmed">36670365</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S., Catalogna M., Sasson E., Elman-Shina K., Hadanny A., Lang E., Finci S., Polak N., Fishlev G., Korin C., et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: Randomized controlled trial. Sci. Rep. 2022;12:11252. doi: 10.1038/s41598-022-15565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Catalogna M., Sasson E., Hadanny A., Parag Y., Zilberman-Itskovich S., Efrati S. Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: A randomized, sham-controlled trial. Neuroimage Clin. 2022;36:103218. doi: 10.1016/j.nicl.2022.103218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2022.103218</ArticleId><ArticleId IdType="pmc">PMC9528018</ArticleId><ArticleId IdType="pubmed">36208548</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitman M., Fuchs S., Tyomkin V., Hadanny A., Zilberman-Itskovich S., Efrati S. The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: A randomized controlled trial. Sci. Rep. 2023;13:9473. doi: 10.1038/s41598-023-36570-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-36570-x</ArticleId><ArticleId IdType="pmc">PMC10257166</ArticleId><ArticleId IdType="pubmed">37301934</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjellberg A., Abdel-Halim L., Hassler A., El Gharbi S., Al-Ezerjawi S., Bostr&#xf6;m E., Sundberg C.J., Pernow J., Medson K., Kowalski J.H., et al. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): Protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial. BMJ Open. 2022;12:e061870. doi: 10.1136/bmjopen-2022-061870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-061870</ArticleId><ArticleId IdType="pmc">PMC9638753</ArticleId><ArticleId IdType="pubmed">36323462</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>